Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,588 | Dovepress* | 6,946+ | 910 | 7,856 | |
| PubMed Central* | 1,642 | 305 | 1,947 | ||
| Totals | 8,588 | 1,215 | 9,803 | ||
| *Since 19 September 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 1 | 4 |
View citations on PubMed Central and Google Scholar